Robert Hazlett analyst

Currently out of the existing stock ratings of Robert Hazlett, 80 are a BUY (89.89%), 8 are a HOLD (8.99%), 1 are a SELL (1.12%).

Robert Hazlett

Work Performance Price Targets & Ratings Chart

Analyst Robert Hazlett, carries an average stock price target met ratio of 37.5% that have a potential upside of 47.72% achieved within 301 days. Previously, Robert Hazlett worked at BTIG, LADENBURG.

Robert Hazlett’s has documented 157 price targets and ratings displayed on 27 stocks. The coverage was on Healthcare, Industrials, Technology, Consumer Cyclical, Energy sectors.

Most recent stock forecast was given on CMPS, Compass Pathways Plc at 24-Jun-2025.

Wall Street Analyst Robert Hazlett

Analyst best performing recommendations are on AXSM (AXSOME THERAPEUTICS).
The best stock recommendation documented was for AXSM (AXSOME THERAPEUTICS) at 12/17/2019. The price target of $97 was fulfilled within 3 days with a profit of $16.03 (19.8%) receiving and performance score of 65.99.

Average potential price target upside

ITCI Intracellular Th MNKD MannKind Corp PRTA Prothena plc RDHL Redhill Biopharma Ltd SEEL Seelos Therapeutics ZSAN Zosano Pharma Corp AXSM Axsome Therapeutics GRTX Galera Therapeutics NKTR Nektar Therapeutics EIGR Eiger Biopharmaceuticals FIXX Homology Medicines VSTM Verastem ARAV Aravive AKBA Akebia Ther AURA Aura Biosciences LYRA Lyra Therapeutics  PRTK Paratek Pharmaceuticals CMPS Compass Pathways Plc RANI Rani Therapeutics Holdings SNDX Syndax Pharmaceuticals NXTC NextCure  EIG Employers Holdings FIX Comfort Systems USA IT Gartner SEE Sealed Air AR Antero Resources Corp ZS Zscaler

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 02-Apr-2025

$132

$0.13 (0.10%)

$132

1 years 3 months 6 days ago
(02-Apr-2025)

27/29 (93.1%)

$0.13 (0.10%)

494

Hold Since 28-Feb-2025

$132

$0.13 (0.10%)

$132

1 years 4 months 10 days ago
(28-Feb-2025)

12/15 (80%)

$3.8 (2.96%)

738

Buy Since 10-Dec-2020

$132

$0.13 (0.10%)

$100

1 years 4 months 14 days ago
(24-Feb-2025)

14/15 (93.33%)

$3.43 (2.67%)

274

Hold Since 21-Feb-2025

$100

1 years 4 months 17 days ago
(21-Feb-2025)

24/25 (96%)

$-27.19 (-21.38%)

152

Hold Since 08-Aug-2024

$132

$0.13 (0.10%)

$87

1 years 5 months 3 days ago
(05-Feb-2025)

8/9 (88.89%)

$4.97 (3.91%)

227

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Robert Hazlett?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?